Gilead Sciences (GILD) announced the CHMP of the EMA has adopted a positive opinion, recommending the marketing authorization of Trodelvy as a monotherapy for the treatment of adult patients with unresectable locally advanced or TNBC

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Mexican GDP Growth Rate QoQ Final (Q1) Q/Q -0.6% vs. Exp. -0.8% (Prev. 0.9%)

Chinese EV battery giant CATL is planning to invest in DeepSeek, The Information reports

Gilead Sciences (GILD) announced the CHMP of the EMA has adopted a positive opinion, recommending the marketing authorization of Trodelvy as a monotherapy for the treatment of adult patients with unresectable locally advanced or TNBC

PRIMER - Today’s Fedspeak includes: Waller; Warsh will be sworn in as Fed Chair at the White House

US President Trump posts "new stock market record!"

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free